The adult cerebral cortex retains a capacity for change, but the extracellular matrix often limits the scale and direction of that reorganization after injury. Work by Elizabeth Bradbury and James Fawcett at the University of Cambridge demonstrated that digestion of chondroitin sulfate proteoglycans with the enzyme chondroitinase ABC enhanced axonal sprouting and functional recovery in spinal cord injury models, indicating that matrix components actively constrain structural plasticity. Jerry Silver at Case Western Reserve University and colleagues showed that proteoglycans deposited in and around the injury site inhibit neurite outgrowth, establishing a biochemical barrier to regrowth.
Mechanisms and experimental evidence
Key matrix elements are perineuronal nets and chondroitin sulfate proteoglycans which surround neuronal cell bodies and synapses and stabilize synaptic contacts. Antonio Pizzorusso at the University of Milan and collaborators found that enzymatically removing perineuronal nets reactivated ocular dominance plasticity in adult visual cortex, providing direct experimental evidence that the matrix gates experience-dependent remapping. Mechanistically, the matrix restricts receptor mobility, limits dendritic spine remodeling, and binds growth-inhibitory molecules, so injury-induced upregulation of these molecules produces both physical and biochemical constraints on new connections.
Relevance, causes, and consequences
Clinically, the matrix’s inhibitory role helps explain why stroke and traumatic brain injury produce chronic deficits despite spontaneous peri-lesional plasticity. The immediate cause is a reactive multicellular response: injured neurons, astrocytes, and extracellular matrix enzymes alter composition so that inhibitory proteoglycans accumulate. Consequences include limited recovery of lost functions, maladaptive reorganization when only partial rewiring occurs, and potential for chronic pain or epilepsy if inhibition is reduced indiscriminately.
Translational nuance matters. Experimental removal of matrix constraints in rodents improves outcomes, but human cortex differs in scale, cell types, and perineuronal net distribution, so interventions that worked in animal studies require careful dosing, timing, and delivery. There are also cultural and territorial dimensions: access to advanced biologic therapies and rehabilitation varies widely between health systems, affecting who benefits from emerging treatments.
Overall, evidence from established laboratories at the University of Cambridge, Case Western Reserve University, and the University of Milan supports the conclusion that the extracellular matrix constrains cortical reorganization after injury, while also identifying a targetable mechanism that, with cautious development, could expand therapeutic options for human brain repair.